Elevated Serum Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Could be Useful in Lung Cancer Diagnosis |
Kemal, Yasemin
(Department of Medical Oncology, Faculty of Medicine, 19 Mayis Univercity)
Yucel, Idris (Department of Medical Oncology, Faculty of Medicine, 19 Mayis Univercity) Ekiz, Kubilay (Department of Internal Medicine, Faculty of Medicine, 19 Mayis Univercity) Demirag, Guzin (Department of Medical Oncology, Faculty of Medicine, 19 Mayis Univercity) Yilmaz, Bahiddin (Department of Medical Oncology, Faculty of Medicine, 19 Mayis Univercity) Teker, Fatih (Department of Medical Oncology, Faculty of Medicine, 19 Mayis Univercity) Ozdemir, Meltem (Department of Internal Medicine, Faculty of Medicine, 19 Mayis Univercity) |
1 | Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42. DOI ScienceOn |
2 | Suzuki K, Kachala SS, Kadota K et al (2011). Prognostic immune markers in non-small cell lung cancer. Clin Cancer Res, 17, 5247-56. DOI ScienceOn |
3 | Thavaramara T, Phaloprakarn C, Tangjitgamol S et al (2011). Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. J Med Assoc Thai, 94, 871-7. |
4 | Walsh SR, Cook EJ, Goulder F et al (2005). Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol, 91, 181-4. DOI ScienceOn |
5 | Wiesner T, Bugl S, Mayer F, et al (2010). Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer. Clin Exp Metastasis, 27, 141-9. DOI |
6 | Ohashi R, Takahashi K, Miura K et al (2006). Prognostic factors in patients with inoperable non-small cell lung cancer-an analysis of long-term survival patients. Gan To Kagaku Ryoho, 33, 1595-602. |
7 | Lee Y, Kim SH, Han JY, et al (2012). Early neutrophil-tolymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. J Cancer Res Clin Oncol, 138, 2009-16. DOI ScienceOn |
8 | Mangalpally KK, Siqueiros-Garcia A, Vaduganathan M (2010). Platelet activation patterns in plateletsize sub-populations: differential responses to aspirin in vitro. J Thromb Thrombolysis, 30, 251-62. DOI |
9 | Mantovani A, Allavena P, Sica A, Ballkwill F (2008). Cancerrelated inflammation. Nature, 454, 436-44 DOI ScienceOn |
10 | Petrie HT, Klassen LW, Kay HD(1985). Inhibition of human Cytotoxic T lymphocyte activity in vitro By autologous peripheral blood granulocytes. J Immunol, 134, 230-4. |
11 | Sandler A, Gray R, Perry M, et al (2006). Paclitaxel-carboplatin alone or with bevacizumab in non-small cell lung cancer. NEJM, 355, 2542-50. DOI ScienceOn |
12 | Holmes CE, Levis JE, Ornstein DL (2009). Activated platelets enhance ovarian cell invasion in a cellular model of metastasis. Clin Exp Metastasis, 26, 653-61. DOI |
13 | Schreiber RD, Old LJ, Smyth MJ (2011). Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science, 331, 1565-70. DOI ScienceOn |
14 | Sharaiha RZ, Halazun KJ, Mirza F, et al (2011). Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol, 18, 3362-9. DOI ScienceOn |
15 | Smith R, Bosonnet L, Raraty M, et al (2009). Preoperative plateletlymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg, 197, 466-72. DOI ScienceOn |
16 | Groome PA, Bolejack V, Crowley JJ et al (2007). The IASLC Lung Cancer Staging Project: validation of the proposal for revision of the T, N and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thorac Oncol, 2, 694-705. DOI |
17 | Gwak MS, Choi SJ, Kim JA et al (2007). Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer. J Korean Med, 22, 104-8. DOI ScienceOn |
18 | Howlader N, Noone AM, Krapcho M, et al (2009). SEER Cancer Statistics Review 1975-2009 (Vintage: Populations), Bethesda, MD, National Cancer Institute. |
19 | Jemal A, Bray F, Center MM et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
20 | Kai H, Kitadai Y, Kodama M Cho S, Kuroda T, Ito M et al (2005). Involvement of proinflammatory cytokinesIL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res, 25, 709-13. |
21 | Balkwill F, Mantovani A (2001). Inflammation and cancer: back toVirchow? Lancet, 357, 539-45. DOI ScienceOn |
22 | Kaya V, Yildirim M, Demirpence O, Yildiz M, Yalcin AY (2013). Prognostic significance of basic laboratory methods in nonsmall- cell-lung cancer. Asian Pac J Cancer Prev, 14, 5473-6. DOI ScienceOn |
23 | Kilincalp S, Ekiz F, Basar O, et al (2013). Platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets, [Epub ahead of print]. |
24 | Azab B, Bhatt VR, Phookan J et al (2012). Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol, 19, 217-24. DOI ScienceOn |
25 | Bambace NM, Holmes CE (2011). The platelet contribution to cancer progression. J Thromb Haemost, 9, 237-49. DOI ScienceOn |
26 | Benoy I, Salgado R, Colpaert C, et al (2002). Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer, 2, 311-5. DOI ScienceOn |
27 | De Larco JE, Wuertz BRK, Furcht LT (2004). The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res, 10, 4895-900. DOI ScienceOn |
28 | Donnem T, Bremnes RM, Busund LT et al (2012). Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer. J Thorac Dis, 4, 212-3. |
29 | Dvorak HF, Brown LF, Detmar M, et al(1995).Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol, 146, 1029-39. |
30 | Fidler IJ (2003). The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer, 3, 453-8. DOI ScienceOn |
31 | Hoang T, Xu R, Schiller JH et al (2005). Clinical model to predict survival in chemo-naive patients with advanced non-small cell lung cancer treated with third generation chemotherapy regimen based on eastern cooperative oncology group data. J Clin Oncol, 23, 175-83. DOI ScienceOn |
32 | Tanner NT, Sherman CA, Silvestri GA (2012). Biomarkers in the selection of maintenance therapy in nonsmall cell lung cancer. Transl Lung Cancer Res, 1, 96-8. |